• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Mannatech Inc

+ Add to Watchlist


12.9738 USD 0.0562 0.43%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Mannatech Inc (MTEX)

Open: 12.9738 Day's Range: 12.9738 - 12.9738 Volume: 267
Previous Close: 13.0300 52wk Range: 11.5100 - 35.0000 1-Yr Rtn: -53.18%

Stock Chart for MTEX

No chart data available.
  • MTEX:US 12.9738
  • 1D
  • 1M
  • 1Y
Interactive MTEX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MTEX

Current P/E Ratio (ttm) 28.2039
Estimated P/E(-) -
Relative P/E vs. SPX 1.5718
Earnings Per Share (ttm) 0.4600
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 34.60
Shares Outstanding (M) 2.67
30 Day Average Volume 6,841
Price/Book (mrq) 1.4423
Price/Sale (ttm) 0.1911
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 08/21/2009
5 Year Dividend Growth -
Next Earnings Announcement 11/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MTEX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MTEX

Mannatech, Incorporated develops and sells proprietary nutritional supplements and topical products through a network marketing system of independent distrib- utors. The Company's Ambrotose complex is an ingredient made from naturally- occurring sugars, which it includes in its products. Mannatech currently sells its products in the United States, Canada, and Australia.

Robert A Sinnott "Rob"CEO/Chief Science OfficerAlfredo Bala "Al"President
S Mark NichollsChief Financial OfficerJoel BikmanChief Marketing Officer
More Company Profile & Key Executives for MTEX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil